PRQR Stock Summary and Trading Ideas (Proqr Therapeutics N.V. - | NASDAQ:PRQR)

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Proqr Therapeutics N.V. - trades on the NASDAQ stock market under the symbol PRQR.

As of December 13, 2024, PRQR stock price declined to $2.91 with 549,465 million shares trading.

PRQR has a beta of 0.98, meaning it tends to be less sensitive to market movements. PRQR has a correlation of 0.01 to the broad based SPY ETF.

PRQR has a market cap of $308.19 million. This is considered a Small Cap stock.

Last quarter Proqr Therapeutics N.V. - reported $4 million in Revenue and -$.11 earnings per share. This fell short of revenue expectation by $-8 million and met earnings estimates .

In the last 3 years, PRQR traded as high as $8.60 and as low as $.53.

The top ETF exchange traded funds that PRQR belongs to (by Net Assets): AVDV, AVDS.

PRQR has outperformed the market in the last year with a return of +42.0%, while the SPY ETF gained +31.7%. In the last 3 month period, PRQR beat the market returning +57.3%, while SPY returned +8.4%. However, in the most recent 2 weeks PRQR has underperformed the stock market by returning -20.7%, while SPY returned +0.9%.

PRQR support price is $3.17 and resistance is $3.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRQR shares will trade within this expected range on the day.